Catechins supplementation studies

Capillary electrophoresis (CE) is an emerging analytical technique for determination of catechins. The majority of CE studies involve the analysis of catechins in tea infusion, extracts as well as supplements. The three variants of CE suitable for the analysis of catechins include capillary zone electrophoresis (CZE), micellar electro-kinetic chromatography (MEKC), and microemulsion electrokinetic chromatography (MEEKC) with UV detection. In general, the resolution of MEKC was found to be superior to CZE for separation of catechins. MEEKC is a relatively new technique, and the few reports available suggest that it offers a performance similar to MEKC. CE conditions are often quite complex, and many factors, such as buffer composition, pH, presence of surfactants, and column temperature, can all affect the quality of separation and should be optimized individually. On the other hand, CE offers several advantages over HPLC. The short analysis time (<20 minutes), low running costs, and reduced use of solvents make it an attractive alternative for routine analysis of catechins. 

Phenolic substances in red wine were shown to inhibit LDL oxidation in vitro [95]. In previous studies, red wine-derived phenolic acids [115,116], resveratrol [117], flavonols (quercetin, myricetin) [68,118,119], catechins [66,120], and the grape extract itself [121,122] have been shown to possess antioxidant properties. The finding that ethanol and wine stripped of phenols did not affect LDL oxidation further confirmed that the active antioxidant components in red wine are phenolic compounds [123]. Red wine fractionation revealed major antioxidative potency to monomeric catechins, procyanidins, monomeric anthocyanidins, and phenolic acids [123]. The flavonol quercetin and the flavonol catechin were both tested for antioxidative and antiatherogenic effects in the atherosclerotic E° mice [111]. E° mice at the age of 4 weeks were supplemented for up to 6 weeks in their drinking water with placebo (1.1% alcohol) or with catechin or quercetin (50 pg/day/mouse). The atherosclerotic lesion area was smaller by 39% or by 46%, respectively, in the treated mice than in E° mice that were treated with placebo (Fig. 4A-E). 

---